Single User License
INR 102030
Site License
INR 204060
Corporate User License
INR 306090

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Prometheon Pharma, LLC-Product Pipeline Review-2016

Prometheon Pharma, LLC-Product Pipeline Review-2016


  Request for Sample Report

Executive Summary

Prometheon Pharma, LLC-Product Pipeline Review-2016

Summary

Global Markets Direct's, 'Prometheon Pharma, LLC-Product Pipeline Review-2016', provides an overview of the Prometheon Pharma, LLC's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Prometheon Pharma, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Prometheon Pharma, LLC

The report provides overview of Prometheon Pharma, LLC including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Prometheon Pharma, LLC's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Prometheon Pharma, LLC's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

Evaluate Prometheon Pharma, LLC's strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Prometheon Pharma, LLC

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Prometheon Pharma, LLC's pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Prometheon Pharma, LLC Snapshot 5

Prometheon Pharma, LLC Overview 5

Key Facts 5

Prometheon Pharma, LLC-Research and Development Overview 6

Key Therapeutic Areas 6

Prometheon Pharma, LLC-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Pipeline Products-Combination Treatment Modalities 11

Prometheon Pharma, LLC-Pipeline Products Glance 12

Prometheon Pharma, LLC-Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Discovery Products/Combination Treatment Modalities 13

Prometheon Pharma, LLC-Drug Profiles 14

(measles + mumps + rubella) vaccine-Drug Profile 14

Product Description 14

Mechanism Of Action 14

R&D Progress 14

diphtheria vaccine-Drug Profile 15

Product Description 15

Mechanism Of Action 15

R&D Progress 15

Drug to Agonize GLP-1 for Type I and Type II Diabetes-Drug Profile 16

Product Description 16

Mechanism Of Action 16

R&D Progress 16

Drug to Inhibit DPP-1 for Type I and Type II Diabetes-Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

Drug to Inhibit SGLT-2 for Type I and Type II Diabetes-Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

insulin human-Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

pneumococcal vaccine-Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

Protein to Agonize Insulin Like Growth Factor 1 Receptor for Hormone Replacement Therapy-Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

sertraline hydrochloride-Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

Small Molecules to Inhibit TRIP-Br2 for Obesity and Insulin Resistance-Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

somatropin-Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

tetanus vaccine-Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

Prometheon Pharma, LLC-Pipeline Analysis 26

Prometheon Pharma, LLC-Pipeline Products by Target 26

Prometheon Pharma, LLC-Pipeline Products by Route of Administration 27

Prometheon Pharma, LLC-Pipeline Products by Molecule Type 28

Prometheon Pharma, LLC-Pipeline Products by Mechanism of Action 29

Prometheon Pharma, LLC-Locations And Subsidiaries 30

Head Office 30

Appendix 31

Methodology 31

Coverage 31

Secondary Research 31

Primary Research 31

Expert Panel Validation 31

Contact Us 31

Disclaimer 32

List of Figures

Prometheon Pharma, LLC-Pipeline by Top 10 Indication, 2016 7

Prometheon Pharma, LLC-Pipeline by Stage of Development, 2016 9

Prometheon Pharma, LLC-Monotherapy Products in Pipeline, 2016 10

Prometheon Pharma, LLC-Pipeline by Target, 2016 26

Prometheon Pharma, LLC-Pipeline by Route of Administration, 2016 27

Prometheon Pharma, LLC-Pipeline by Molecule Type, 2016 28

Prometheon Pharma, LLC-Pipeline Products by Mechanism of Action, 2016 29

List of Tables

Prometheon Pharma, LLC, Key Facts 5

Prometheon Pharma, LLC-Pipeline by Indication, 2016 8

Prometheon Pharma, LLC-Pipeline by Stage of Development, 2016 9

Prometheon Pharma, LLC-Monotherapy Products in Pipeline, 2016 10

Prometheon Pharma, LLC-Combination Treatment Modalities in Pipeline, 2016 11

Prometheon Pharma, LLC-Preclinical, 2016 12

Prometheon Pharma, LLC-Discovery, 2016 13

Prometheon Pharma, LLC-Pipeline by Target, 2016 26

Prometheon Pharma, LLC-Pipeline by Route of Administration, 2016 27

Prometheon Pharma, LLC-Pipeline by Molecule Type, 2016 28

Prometheon Pharma, LLC-Pipeline Products by Mechanism of Action, 2016 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Prometheon Pharma, LLC; Prometheon Pharma, LLC-Key Therapeutics; Prometheon Pharma, LLC-Pipeline Overview and Promising Molecules; Prometheon Pharma, LLC-News; Prometheon Pharma, LLC-Latest Updates; Prometheon Pharma, LLC-Pipeline; Prometheon Pharma, LLC-Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com